Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Urolithin C
Cat. No.:
0225LY-1409
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Urolithin C is a gut-derived metabolite of ellagic acid that triggers apoptosis in PC12 cells by engaging a pathway mediated by the mitochondria.
Synonym:
165393-06-6; 3,8,9-Trihydroxy-6H-benzo[c]chromen-6-one; Urolithin-C; 6H-Dibenzo[b,d]pyran-6-one, 3,8,9-trihydroxy-; 3,8,9-trihydroxy-urolithin; 3,8,9-trihydroxybenzo(c)chromen-6-one; 3,8,9-trihydroxy-6H-benzo(c)chromen-6-one
CAS No.:
165393-06-6
Compound CID:
60198001
Formula:
C13H8O5
Formula Weight:
244.2
Specification
Relative Density:
1.640 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Urolithin C can be used in aging research or play an important role in studies concerning mitochondrial health and intestinal barrier function.
Library Information
Target:
IGF-1R; Calcium channel
Receptor:
Calcium channel; Insulin receptor
Pathways:
Tyrosine kinase/adaptors; Apoptosis; Membrane transporter/Ion channel; Immunology/Inflammation; Metabolism; NF-κB
Plate Number:
AOCL-19
Plate Location:
b2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
64.67 mg/mL; 264.82 mM
